BioAtla, Inc. (BCAB)
NASDAQ·Healthcare·Biotechnology
$3.87
+8.71%
Mkt Cap $5.31M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$5.00
Range $5.00 – $5.00
Implied Upside
+29.2%
Consensus $5.00 vs current $3.87
NASDAQ·Healthcare·Biotechnology
$3.87
+8.71%
Mkt Cap $5.31M
No recent rating data.
Price Target (1 analysts)
$5.00
Range $5.00 – $5.00
+29.2%
Consensus $5.00 vs current $3.87